Back to UBS Group AG UBS Group AG

KZIAKZIA
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in KAZIA THERAPEUTICS LTD

UBS Group AG holds 81,090 shares of KZIA (KAZIA THERAPEUTICS LTD), worth $1.1M as of 2026-Q2. The position was increased (+482.0% shares). KZIA represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.1M

Current Shares

81,090

Total Value Change

+$1.1M

Total Shares Change

+78,061

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
81,090
+482.0%
$1.1M0.0%$14.08
41
2026-Q1
Increased
13,934
+7119.7%
$103,6680.0%$10.01
24
2025-Q4
Decreased
193
-94.5%
$1,3300.0%$6.46
0
2025-Q3
Increased
3,543
+17.0%
$25,5450.0%$7.47
15
2025-Q2
New
3,029
-
$18,9920.0%$6.34
28

Other major holders of KZIA: Alyeska Investment Group, L.P., Point72 Asset Management, L.P., Ensign Peak Advisors, Inc, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used